Vers de nouvelles recommandations pour la chirurgie du diabète de type 2 ?

Bariatric surgery has emerged as an effective treatment not only for obesity, but also for type 2 diabetes mellitus (T2DM). Recent meta-analysis reported the complete resolution of T2DM in 78% of cases of morbidly obese patients after bariatric surgery, especially after a Roux-en-Y gastric bypass. Such results obtained in diabetic populations with body mass index (BMI) scores >35 kg/m2 have suggested that bariatric surgery may also be an innovative therapy for T2DM. In addition, because metabolic improvement after bariatric surgery is not completely related to body weight loss, the term “metabolic surgery” emerged as a more appropriate word for the surgical treatment of T2DM. Metabolic surgery for T2DM patients with BMI <35 kg/m2 can now be considered after the publication in 2016 of a new guideline validated by International Diabetes Organizations. Thus, metabolic surgery will be progressively included in worldwide clinical practice recommendations for T2DM therapeutic management.